Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) describes a condition in which the liver stores excess fat but is not secondary to alcohol, a virus, drugs, metabolic disorders, syndromes and other factors that may affect the liver’s ability to metabolize or export fat. NAFLD is currently the most common cause of abnormal liver blood tests in the United States.
The disease process is usually associated with obesity, abnormal lipid levels (high cholesterol), diabetes, and prediabetes. Severity of NAFLD can range from fat storage in the liver, fat and inflammation in the liver (called NASH or nonalcoholic steatohepatitis), fat and inflammation with a lot of scar tissue in the liver (cirrhosis due to NASH).
Listen to a BlogTalkRadio program about nonalcoholic fatty liver disease featuring Dr. Julia Wattacheril, from the Division of Digestive and Liver Diseases and Dr. Joel Lavine, Chief of Gastroenterology, Hepatology and Nutrition at MSCHONY.
Numerous clinical trials for NASH and NAFLD are ongoing at NewYork-Presbyterian/Columbia. If you are interested in learning more about clinical trials offered at our center, please see here.